Neurotrope, Inc.
205 East 42nd Street – 16th Floor
New York, New York 10017
April 19, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes, Assistant Director
RE: | Neurotrope, Inc. Registration Statement on Form S-3 |
File No. 333-217089
Acceleration Request
Dear Ms. Hayes:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Neurotrope, Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Registration Statement to Friday, April 21, 2017, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Jeffrey Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (212) 692-6732 with any comments or questions regarding the Registration Statement.
Very truly yours, | |
Neurotrope, Inc. | |
/s/ Robert Weinstein | |
By: Robert Weinstein | |
Its: Chief Financial Officer,
Treasurer, Secretary and Executive Vice President |
cc: | Mary Beth Breslin, Securities and Exchange Commission |
Jeffrey Gabor, Securities and Exchange Commission
Jeffrey Schultz, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.